BACKGROUND: The purpose of this study was to examine the role of erythropoietin in retinal ischemic preconditioning (IPC). METHODS: Rats were subjected to retinal ischemia after IPC. Electroretinography assessed functional recovery after ischemia; retinal sections were examined to determine loss of retinal ganglion cells, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling was used to assess apoptosis. Levels of downstream mediators were measured in retinal homogenates by Western blotting. To assess the involvement of erythropoietin in IPC, Western blotting was used to measure levels of erythropoietin and its receptor (EPO-R) in retinal homogenates after IPC. To examine erythropoietin's role in IPC, the impact of blocking erythropoietin via intravitreal injection of soluble EPO-R (sEPO-R) before IPC was studied. RESULTS: Erythropoietin levels did not change after IPC, but EPO-R increased. Intravitreal injection of sEPO-R significantly attenuated both the functional and histologic neuroprotection produced by IPC in comparison to control injection of denatured sEPO-R. Apoptotic damage after ischemia was enhanced in the sEPO-R-treated retinas as indicated by fluorescent terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling. Phosphorylated extracellular-signal-regulated kinase and heat shock protein 27, but not protein kinase B, upregulated in denatured sEPO-R-treated retinae, were attenuated in eyes injected with sEPO-R. CONCLUSIONS: These results indicate that EPO-R upregulation is a critical component of the functional, histologic, and antiapoptotic protective effect of IPC on ischemia in the retina and that several downstream effectors may be involved in the neuroprotective actions of erythropoietin.
BACKGROUND: The purpose of this study was to examine the role of erythropoietin in retinal ischemic preconditioning (IPC). METHODS:Rats were subjected to retinal ischemia after IPC. Electroretinography assessed functional recovery after ischemia; retinal sections were examined to determine loss of retinal ganglion cells, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling was used to assess apoptosis. Levels of downstream mediators were measured in retinal homogenates by Western blotting. To assess the involvement of erythropoietin in IPC, Western blotting was used to measure levels of erythropoietin and its receptor (EPO-R) in retinal homogenates after IPC. To examine erythropoietin's role in IPC, the impact of blocking erythropoietin via intravitreal injection of soluble EPO-R (sEPO-R) before IPC was studied. RESULTS:Erythropoietin levels did not change after IPC, but EPO-R increased. Intravitreal injection of sEPO-R significantly attenuated both the functional and histologic neuroprotection produced by IPC in comparison to control injection of denatured sEPO-R. Apoptotic damage after ischemia was enhanced in the sEPO-R-treated retinas as indicated by fluorescent terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling. Phosphorylated extracellular-signal-regulated kinase and heat shock protein 27, but not protein kinase B, upregulated in denatured sEPO-R-treated retinae, were attenuated in eyes injected with sEPO-R. CONCLUSIONS: These results indicate that EPO-R upregulation is a critical component of the functional, histologic, and antiapoptotic protective effect of IPC on ischemia in the retina and that several downstream effectors may be involved in the neuroprotective actions of erythropoietin.
Authors: M Bernaudin; H H Marti; S Roussel; D Divoux; A Nouvelot; E T MacKenzie; E Petit Journal: J Cereb Blood Flow Metab Date: 1999-06 Impact factor: 6.200
Authors: S Roth; B Li; P S Rosenbaum; H Gupta; I M Goldstein; K M Maxwell; J M Gidday Journal: Invest Ophthalmol Vis Sci Date: 1998-04 Impact factor: 4.799
Authors: Ulkan Kilic; Ertugrul Kilic; Jorge Soliz; Claudio I Bassetti; Max Gassmann; Dirk M Hermann Journal: FASEB J Date: 2004-11-19 Impact factor: 5.191
Authors: Tonia S Rex; Mariacarmela Allocca; Luciano Domenici; Enrico M Surace; Albert M Maguire; Arkady Lyubarsky; Alessandro Cellerino; Jean Bennett; Alberto Auricchio Journal: Mol Ther Date: 2004-11 Impact factor: 11.454
Authors: John C Dreixler; Anthony Bratton; Eugenie Du; Afzhal R Shaikh; Brian Savoie; Michael Alexander; Marcus M Marcet; Steven Roth Journal: Exp Eye Res Date: 2010-11-20 Impact factor: 3.467
Authors: John C Dreixler; Ajay Sampat; Afzhal R Shaikh; Michael Alexander; Marcus M Marcet; Steven Roth Journal: J Mol Neurosci Date: 2011-05-15 Impact factor: 3.444
Authors: Freya M Mowat; Francisco Gonzalez; Ulrich F O Luhmann; Clemens A Lange; Yanai Duran; Alexander J Smith; Patrick H Maxwell; Robin R Ali; James W B Bainbridge Journal: Am J Pathol Date: 2012-02-17 Impact factor: 4.307
Authors: John C Dreixler; Jacqueline N Poston; Afzhal R Shaikh; Michael Alexander; Kelsey Y Tupper; Marcus M Marcet; Myriam Bernaudin; Steven Roth Journal: Exp Eye Res Date: 2011-04-09 Impact factor: 3.467
Authors: John C Dreixler; Jacqueline N Poston; Irina Balyasnikova; Afzhal R Shaikh; Kelsey Y Tupper; Sineadh Conway; Venkat Boddapati; Marcus M Marcet; Maciej S Lesniak; Steven Roth Journal: Invest Ophthalmol Vis Sci Date: 2014-04-03 Impact factor: 4.799